The Named Patient Import Program helps allow access to medicines not yet available or approved in a patient's home country. Under the named patient import service, certain treatments that might not be locally accessible can be accessed with the help of Ikris Pharma Network (IPN). IPN plays a key role in helping healthcare professionals and patients obtain unregistered or unavailable medicines through this program. As a trusted facilitator, Ikris ensures the smooth delivery of life-saving medicines. This program helps individuals to access critical treatments while adhering to local regulations and requirements. Kindly call/WhatsApp: +91 9654860915 to learn more.